Toronto – October 14, 2026 -- Deloitte Consulting LLP will demonstrate live how AI-enabled case intake can handle incoming adverse event data in pharmacovigilance during an Xtalks webinar on Wednesday, October 28, 2026, at 1pm EDT (10am PDT).
Deloitte executives to demo ElevateSafety and Detective on Converge
Cyle Connell, Associate Vice President of Product Management for ElevateSafetyTM, and Ellen O'Dea, Senior Manager, both of Deloitte Consulting LLP, will lead the session. The demonstration covers ElevateSafetyTM and Detective, powered by ConvergeTM by Deloitte. It will show AI-enabled detection, data structuring, quality checks and routing across diverse data sources.
Manual review still dominates case assessment, classification and routing
Potential adverse events and product quality complaints reach safety teams through emails, websites and portals, chatbots, call centers and digital formats such as xml. Automation is entering this intake process, but most pharmacovigilance teams still rely on heavily manual reviews to assess, classify and route each potential case, according to the organizers.
Session targets quality controls and traceability in a regulated environment
The agenda covers embedded quality checks, transparent confidence indicators, auditability, and end-to-end traceability of extracted information and the decisions that follow from it. Human oversight stays in place. The stated aim is to automate appropriate activities and direct expert attention to where it adds the most value.
The webinar is aimed at organizations evaluating AI for the first time and at those benchmarking an existing approach in pharmaceutical and life sciences safety operations.